NEW YORK--(BUSINESS WIRE)--Jun. 26, 2015--
Regulatory News:
Philip Morris International Inc. (NYSE / Euronext Paris: PM) (“PMI”)
today announced that its subsidiary, PT HM Sampoerna Tbk. (IDX: HMSP)
(“Sampoerna”), in which it holds a 98.18% interest, will explore options
to comply with the Indonesian Stock Exchange’s mandatory requirement of
a minimum threshold for public shareholding.
On January 30, 2014, IDX introduced a regulation requiring all listed
public companies to have at least 7.5% of their total paid up capital
owned by the public by January 30, 2016.
Sampoerna has engaged investment banks to assist with the evaluation of
various strategic options to fulfill this requirement. These include
potential capital market transactions.
About PT HM Sampoerna Tbk.
PT HM Sampoerna Tbk. (“Sampoerna”) was founded in 1913 and today is
Indonesia’s largest tobacco company with a cigarette market share in
2014 of 34.9%. At an industry size of 314 billion units in 2014,
Indonesia is the largest cigarette market outside of the People’s
Republic of China. Sampoerna’s brand portfolio includes Sampoerna A and
Dji Sam Soe in the premium price segment and U Mild and Sampoerna
Hijau in the mid-price segment. At the market close on June 26,
2015, Sampoerna had a market capitalization of IDR 313.7 trillion, or
approximately $23.6 billion. For more information, see www.sampoerna.com.
Philip Morris International Inc.
Philip Morris International Inc. (“PMI”) is the leading international
tobacco company, with six of the world’s top 15 international brands,
including Marlboro, the number one cigarette brand worldwide.
PMI’s products are sold in more than 180 markets. In 2014, the company
held an estimated 15.6% share of the total international cigarette
market outside of the U.S., or 28.6% excluding the People’s Republic of
China and the U.S. For more information, see www.pmi.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150626005757/en/
Source: Philip Morris International Inc.
Investor Relations:
New York: +1 (917) 663 2233
Lausanne: +41
(0)58 242 4666
or
Media:
Lausanne: +41 (0)58 242 4500
